Vital Signs - ENTERPRISE CONTENT MANAGEMENT: Sophisticated Tools for Modernized Healthcare Delivery

 


This issue of Vital Signs, released on August 28, 2009, provides a strategic overview of potential benefits and solutions via the implementation of an enterprise content management (ECM) strategy. Additionally, a company spotlight is provided for Neurologix, Inc. a development stage biotechnology company focused on developing treatments for neurological disorders. Reimbursement and regulatory news from the FDA is also provided for the week of August 17, 2009.

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

Table of Contents

Vital Signs - ENTERPRISE CONTENT MANAGEMENT: Sophisticated Tools for Modernized Healthcare DeliveryVital Signs - 28 August 2009This week's issue:




Related Research

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 27-Jul-17

Region : North America

Release Date : 24-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.